| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
/Epidermal Growth Factor Receptor Autocrine Growth Mechanism in an Ovarian Cancer Cell Line in Vitro
Departments of Obstetrics and Gynecology [K-i. M., H. K., K. A., H. A., M. I., A. M., O. T.] and Genetics [Y. S.], Osaka University Medical School 1-1-50 Fukushima, Fukushima-ku, Osaka 553 Japan
Although transforming growth factor (TGF)
and epidermal growth factor (EGF) receptor (EGFR) autocrine mechanism is widely demonstrated in many kinds of cancers, its biological significances still remain circumstantial. We critically assessed the significance of this mechanism on the growth of an ovarian cancer cell line. Northern blot analysis in polyadenylated RNA isolated from cells by using 32P-labeled pre-TGF
, EGFR, and prepro-EGF complementary DNAs as probes revealed that pre-TGF
and EGFR but not prepro-EGF gene transcripts were expressed in the cell. TGF
and EGFR but not EGF proteins were observed by immunocytochemical stainings, using monoclonal antibodies against human TGF
, EGFR, and EGF, respectively. This cell line possessed a class of high affinity EGF receptor by 125I-EGF binding studies; K4 being 2.9 x 1010 M and Bmax to be 7.7 x 104 sites/cell. As much as 1.12 ± 0.14 ng (SD; n = 3)/107 cells/24 h of TGF
was secreted in the conditioned media. These results suggested the expression of a TGF
/EGFR autocrine mechanism in this cell line. We, therefore, assessed the biological significance of this mechanism on the growth of this cell line in serum-free monolayer cell cultures. Although 0.1, 1.0, and 10 nM concentrations of TGF
did not show significant growth promotion, monoclonal antibodies against TGF
and EGFR but not EGF significantly inhibited cell growth. All these data suggested the biological importance of a TGF
/EGFR autocrine mechanism on the growth of this cell line in vitro.
1 To whom requests for reprints should be addressed, at Department of Obstetrics and Gynecology, Osaka University Medical School, 1-1-50 Fukushima, Fukushima-ku, Osaka 553 Japan.
Received 5/28/91. Accepted 8/27/91.
This article has been cited by other articles:
![]() |
L. J. Havrilesky, C. P. McMahon, E. K. Lobenhofer, R. Whitaker, J. R. Marks, and A. Berchuck Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones Reproductive Sciences, April 1, 2001; 8(2): 104 - 113. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |